Clinical trials in Craiova – page 19

322 clinical trials in Craiova, Romania across 3 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.

Our site in RomaniaStudii.Clinice.ro

Craiova at a glance

322

clinical trials

Research sites3

Quick filters

322 trials in Craiova

Open in trial search

Non-small cell lung cancer

Not recruiting

Study on the Effectiveness and Safety of Osimertinib for Patients with Early-Stage Non-Small Cell Lung Cancer After Tumor Removal

Registered drug

Study on the Effectiveness and Safety of Osimertinib for Patients with Early-Stage Non-Small Cell Lung Cancer After Tumor Removal

Registered drug

Romania

Participants:18–64 years · 65+ years
Substances:Osimertinib
Sponsor:AstraZeneca AB

Contact Research Centre

EGFR gene mutation+1

Not recruiting

Study on the Effectiveness and Safety of BAY 2927088 Compared to Standard Treatment in Patients with Advanced Non-Small Cell Lung Cancer with HER2 Mutations

Registered drugNo placebo

Study on the Effectiveness and Safety of BAY 2927088 Compared to Standard Treatment in Patients with Advanced Non-Small Cell Lung Cancer with HER2 Mutations

Registered drugNo placebo

Romania

Participants:18–64 years · 65+ years
Substances:BAY 2927088
Sponsor:Bayer AG

Contact Research Centre

Gastric cancer+1

Not recruiting

Study of Zanidatamab and Tislelizumab Combined with Chemotherapy for Patients with Advanced or Metastatic HER2-positive Gastroesophageal Cancer

Registered drugNo placebo

Study of Zanidatamab and Tislelizumab Combined with Chemotherapy for Patients with Advanced or Metastatic HER2-positive Gastroesophageal Cancer

Registered drugNo placebo

Romania

Participants:18–64 years · 65+ years
Substances:Capecitabine
Sponsor:Jazz Pharmaceuticals Ireland Limited

Contact Research Centre

Triple negative breast cancer

Not recruiting

Study Comparing Sacituzumab Govitecan to Physician's Choice Treatment for Patients with Advanced Triple-Negative Breast Cancer

Registered drugNo placebo

Study Comparing Sacituzumab Govitecan to Physician's Choice Treatment for Patients with Advanced Triple-Negative Breast Cancer

Registered drugNo placebo

Romania

Participants:18–64 years · 65+ years
Substances:Carboplatin
Sponsor:Gilead Sciences Inc.

Contact Research Centre

Chronic hepatitis B

Not recruiting

Study of tenofovir disoproxil versus placebo for children aged 2-12 years with chronic hepatitis B infection

Registered drug

Study of tenofovir disoproxil versus placebo for children aged 2-12 years with chronic hepatitis B infection

Registered drug

Romania

Participants:0–17 years
Substances:Tenofovir Disoproxil
Sponsor:Gilead Sciences Inc.

Contact Research Centre

Malignant peritoneal neoplasm+2

Not recruiting

Study of Rucaparib and Nivolumab for Maintenance Treatment in Patients with Advanced Ovarian, Fallopian Tube, or Primary Peritoneal Cancer After Chemotherapy

Registered drug

Study of Rucaparib and Nivolumab for Maintenance Treatment in Patients with Advanced Ovarian, Fallopian Tube, or Primary Peritoneal Cancer After Chemotherapy

Registered drug

Romania

Participants:18–64 years · 65+ years
Substances:Nivolumab
Sponsor:pharmaand GmbH

Contact Research Centre

Myelofibrosis+1

Not recruiting

Study of Navtemadlin for Patients with Myelofibrosis Resistant to JAK Inhibitors

Registered drugNo placebo

Study of Navtemadlin for Patients with Myelofibrosis Resistant to JAK Inhibitors

Registered drugNo placebo

Romania

Participants:18–64 years · 65+ years
Substances:Danazol
Sponsor:Kartos Therapeutics Inc.

Contact Research Centre

Major depression+1

Not recruiting

Study on Aticaprant and Antidepressant for Preventing Relapse in Adults with Major Depressive Disorder and Anhedonia

Investigational

Study on Aticaprant and Antidepressant for Preventing Relapse in Adults with Major Depressive Disorder and Anhedonia

Investigational

Romania

Participants:18–64 years
Substances:Aticaprant
Sponsor:Janssen Cilag International

Contact Research Centre

Renal cell carcinoma

Not recruiting

Study of Nivolumab and Ipilimumab for Patients with Advanced Kidney Cancer and Intermediate or Poor Risk Factors

Registered drug

Study of Nivolumab and Ipilimumab for Patients with Advanced Kidney Cancer and Intermediate or Poor Risk Factors

Registered drug

Romania

Participants:18–64 years · 65+ years
Substances:Ipilimumab
Sponsor:Bristol-Myers Squibb Services Unlimited Company

Contact Research Centre

Non-small cell lung cancer metastatic

Not recruiting

Study Comparing Ceralasertib and Durvalumab with Docetaxel for Patients with Advanced Non-Small Cell Lung Cancer After Previous Treatments

Registered drugNo placebo

Study Comparing Ceralasertib and Durvalumab with Docetaxel for Patients with Advanced Non-Small Cell Lung Cancer After Previous Treatments

Registered drugNo placebo

Romania

Participants:18–64 years · 65+ years
Substances:Ceralasertib
Sponsor:AstraZeneca AB

Contact Research Centre

Lung neoplasm malignant

Not recruiting

Study on Durvalumab and Domvanalimab for Patients with Stage III Unresectable Non-Small Cell Lung Cancer After Chemoradiation Therapy

Registered drug

Study on Durvalumab and Domvanalimab for Patients with Stage III Unresectable Non-Small Cell Lung Cancer After Chemoradiation Therapy

Registered drug

Romania

Participants:18–64 years · 65+ years
Substances:Domvanalimab
Sponsor:AstraZeneca AB

Contact Research Centre

Postoperative wound infection

Not recruiting

Study on Preventing Infections After Abdominal Surgery Using D-PLEX with Doxycycline Hyclate for Patients Undergoing Abdominal Surgery

InvestigationalNo placebo

Study on Preventing Infections After Abdominal Surgery Using D-PLEX with Doxycycline Hyclate for Patients Undergoing Abdominal Surgery

InvestigationalNo placebo

Romania

Participants:18–64 years · 65+ years
Substances:Doxycycline Hyclate
Sponsor:Polypid Ltd.

Contact Research Centre

Other cities in Romania

The busiest research cities in the country

All 65 cities in Romania

Clinical research in Craiova

What the registry says about research in the country

01 Respiratory Medicine

Current trials focus on innovative treatments for pulmonary conditions, including investigations into new therapies for asthma and pulmonary fibrosis. Research evaluates medication effectiveness in improving lung function and breathing capacity.

Idiopathic Pulmonary Fibrosis
Uncontrolled Asthma
Non-small Cell Lung Cancer

Studies incorporate both targeted therapies and combination treatments to address various stages of respiratory diseases.

02 Oncology

Groundbreaking research in cancer treatment explores novel therapeutic approaches for various types of cancer, with particular focus on gastric, prostate, and lung cancers.

Metastatic Gastric Cancer
Prostate Cancer
Head and Neck Cancer
Breast Cancer

Trials evaluate combination therapies and immunotherapy approaches for improved patient outcomes.

03 Cardiovascular and Metabolic

Studies focus on preventing and treating heart failure and related conditions, with innovative approaches to cardiovascular disease management and metabolic disorders.

Heart Failure Prevention
Chronic Kidney Disease
Cardiovascular Disease
Weight Management

Research emphasizes both preventive strategies and treatment interventions for cardiovascular conditions.

04 Immunology

Advanced research in autoimmune conditions and inflammatory disorders, investigating new therapeutic options for various immune-mediated diseases.

Plaque Psoriasis
Psoriatic Arthritis
Chronic Immune Thrombocytopenia
Chronic Rhinosinusitis

Studies evaluate both targeted therapies and broader immunological approaches.

05 Neurology and Mental Health

Innovative research addressing neurological disorders and mental health conditions, with focus on both therapeutic interventions and disease management.

Alzheimer's Disease Psychosis
Major Depressive Disorder

Trials explore novel treatment approaches for complex neurological and psychiatric conditions.

Back to Romania All countries